CDH2 and cancer: The “cadherin switch”, characterised by the upregulation of N-cadherin and downregulation of E-cadherin, together with the upregulation of intermediated filament proteins, such as vimentin, is intimately connected with increased cell migration and invasion and by consequence augmented cancer aggressiveness [87,88].